Inflammatory markers as diagnostic and precision nutrition tools for metabolic dysfunction-associated steatotic liver disease: Results from the Fatty Liver in Obesity trial
Authors:
Open Access
- 31 May 2024
- journal article
- research article
- Published by Elsevier in Clinical Nutrition
- Vol. 43 (7) , 1770-1781
Abstract
No abstract availableKeywords
Funding Information
- Fundació la Marató de TV3
- Gobierno de España Ministerio de Ciencia, Innovación y Universidades
- CIBER
- Gobierno de Navarra Departamento de Salud
This publication has 47 references indexed in Scilit:
- Associations between dietary inflammatory scores and biomarkers of inflammation in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohortClinical Nutrition, 2023
- Recovery from weight regain among long‐term weight loss maintainers in WWObesity, 2022
- Adipose tissue LECT2 expression is associated with obesity and insulin resistance in Korean womenObesity, 2022
- Intermittent energy restriction ameliorates adipose tissue-associated inflammation in adults with obesity: A randomised controlled trialClinical Nutrition, 2022
- The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?Journal of Hepatology, 2022
- ESPEN practical guideline: Clinical nutrition in liver diseaseClinical Nutrition, 2020
- Effects of plant and animal high protein diets on immune-inflammatory biomarkers: A 6-week intervention trialClinical Nutrition, 2020
- Report on the AASLD/EASL joint workshop on clinical trial endpoints in NAFLDJournal of Hepatology, 2019
- Dietary Inflammatory Index and liver status in subjects with different adiposity levels within the PREDIMED trialClinical Nutrition, 2018
- A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expressionBiochemical Pharmacology, 2015